Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.203ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.203ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.203EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.203EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.203ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.203ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.41EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.41ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.41ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.41EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.41EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.527EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.527EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.527ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.527ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.527EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.527EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.527ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.527ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
C.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
C.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
C.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
C.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.500EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.500ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.500ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.500EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.500EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.500ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.500ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.147EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.147ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.147ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.147EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.147EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.147ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.147ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.46EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.46EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.46ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.46ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used